New hope for vulnerable patients: drug trial targets parainfluenza lung infections
Disease control
Recruiting now
This study tests an experimental drug called DAS181 in people with weakened immune systems who have a parainfluenza infection in their lungs. The goal is to see if the drug helps them breathe without extra oxygen and improves survival. About 274 participants will be randomly assi…
Phase: PHASE3 • Sponsor: Ansun Biopharma, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC